On May 23, 2019, Ways & Means Committee Chairman Richard E. Neal (D-MA) and Energy & Commerce Committee Chairman Frank Pallone, Jr. (D-NJ), along with Ranking Members Kevin Brady (R-TX) and Greg Walden (R-OR) announced a solicitation for … [Read more...] about Center for Medicare Advocacy Submits Comments to House Ways & Means and Energy & Commerce Committees on Draft Part D Legislation
Medicare Part D / Prescription Drugs
Center Comments on Part D Improvements
June 6, 2019Via Electronic Submission to PartDImprovements@mail.house.govThe Honorable Richard Neal The Honorable Frank Pallone Chairman Chairman House … [Read more...] about Center Comments on Part D Improvements
Center for Medicare Advocacy Submits Comments to CMS’ Draft 2020 Call Letter for Medicare Advantage and Part D
On January 30, 2019, the Centers for Medicare & Medicaid Services (CMS) issued Part II of its draft 2020 Call Letter, an annual set of proposed rules, guidelines and clarifications for Part C Medicare Advantage (MA) and Part D plans that want to … [Read more...] about Center for Medicare Advocacy Submits Comments to CMS’ Draft 2020 Call Letter for Medicare Advantage and Part D
State of the Union: Want More Affordable Prescription Drugs? Start with Medicare.
While the President’s State of the Union Address was short on substance concerning health care, he did mention a desire to work with Congress to “lower the cost of health care and prescription drugs.” While the President focused on “global … [Read more...] about State of the Union: Want More Affordable Prescription Drugs? Start with Medicare.
Center Submits Comments on Proposed Medicare Prescription Drug Rule
The Center for Medicare Advocacy recently submitted comments to a Notice of Proposed Rulemaking issued by the Centers for Medicare & Medicaid Services (CMS) entitled “Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce … [Read more...] about Center Submits Comments on Proposed Medicare Prescription Drug Rule
Congressional Hearings Explore Rising Prescription Drug Costs
On January 29, 2019, the Senate and House held separate hearings on prescription drug prices. The Senate Finance Committee’s hearing, Drug Pricing in America: A Prescription for Change, Part 1, explored the rising cost of prescription drugs and … [Read more...] about Congressional Hearings Explore Rising Prescription Drug Costs
Don’t Fall for the Distraction: The President’s Prescription Drug Proposal is Much Ado About Much Too Little
With the mid-term elections just days away, the President unveiled a minimal drug proposal in yet another effort to suggest minor changes at a politically opportune time. This is a distraction from the fact that the Administration is … [Read more...] about Don’t Fall for the Distraction: The President’s Prescription Drug Proposal is Much Ado About Much Too Little
Special Report: Recent Changes in Law, Regulations and Guidance Relating to Medicare Advantage and the Prescription Drug Benefit Program
September 2018Numerous changes were made to Medicare law, regulations and guidance during the first half of 2018.The changes are particularly noteworthy regarding Part C, governing private Medicare plans, known as Medicare Advantage (MA), and … [Read more...] about Special Report: Recent Changes in Law, Regulations and Guidance Relating to Medicare Advantage and the Prescription Drug Benefit Program
Dual Eligibles and Access to Part D Drugs: Pretty Good News from the OIG
The Office of the Inspector General for the Department of Health and Human Services released a report recently regarding Part D coverage of prescription drugs used by people dually eligible for Medicare and Medicaid. The June report, Part D Plans … [Read more...] about Dual Eligibles and Access to Part D Drugs: Pretty Good News from the OIG
The Right Way to Lower Medicare Prescription Drug Costs
Robert Pear wrote last week in the New York Times (“Trump Plan to Lower Drug Prices Could Increase Costs for Some Patients”) that the President’s plan to “inject more competition into the market” and switch coverage of … [Read more...] about The Right Way to Lower Medicare Prescription Drug Costs